Posted by Michael Wonder on 25 Jul 2023
FDA approves Xdemvy (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis
25 July 2023 - Xdemvy expected to be available by prescription by the end of August 2023.
Tarsus Pharmaceuticals today announced that the US FDA approved Xdemvy (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis.
